Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Cash and Equivalents of $68.04 million for fiscal year 2025.
PHIBRO ANIMAL HEALTH CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $68.04M | -3.6% |
| 2024 | $70.61M | +71.1% |
| 2023 | $41.28M | -44.4% |
| 2022 | $74.25M | +47.9% |
| 2021 | $50.21M | +38.2% |
| 2020 | $36.34M | -36.9% |
| 2019 | $57.57M | +97.4% |
| 2018 | $29.17M | -48.0% |
| 2017 | $56.08M | +66.9% |
| 2016 | $33.60M | +15.0% |
| 2015 | $29.22M | +147.2% |
| 2014 | $11.82M | -56.8% |
| 2013 | $27.37M | -49.2% |
| 2012 | $53.90M | +10.9% |
| 2011 | $48.60M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $55.49M | -17.3% | -23.8% |
| September 30, 2025 | $72.77M | +40.4% | +7.0% |
| June 30, 2025 | $68.04M | -3.6% | +12.7% |
| March 31, 2025 | $60.35M | +20.2% | -10.0% |
| December 31, 2024 | $67.07M | +103.4% | +29.4% |
| September 30, 2024 | $51.84M | +20.1% | -26.6% |
| June 30, 2024 | $70.61M | +71.1% | +40.6% |
| March 31, 2024 | $50.23M | +34.9% | +52.3% |
- PHIBRO ANIMAL HEALTH CORP showed a decrease of -3.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2025 period, PHIBRO ANIMAL HEALTH CORP’s cash and equivalents has grown by 40.0% (from $48.60 million to $68.04 million).
- The most recent figure is from PHIBRO ANIMAL HEALTH CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: